July 20/Oak Brook, Ill./PRNewswire -- PureCircle announced that FDA has issued a No Objection letter for the use of PureCircle's SG95 product as a food and beverage ingredient in the United States. This will enable PureCircle to offer a wider and more flexible array of stevia solutions to manufacturers in the U.S. market, the company claims.
PureCircle's high purity SG95 product includes two new steviol glycosides, Rebaudioside D and Rebaudioside F, both of which are receiving GRAS No Objection for the first time. The product is suitable for applications formulated with both sugar and SG95, to achieve a lower-cost solution to partial sugar and calorie reduction. With GRAS affirmation, PureCircle is prepared for immediate commercialization of SG95.